Lisa A De Stefano
Overview
Explore the profile of Lisa A De Stefano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Norris J, De Stefano L, McKinney W, Schmitt L, Miyakoshi M, Gross C, et al.
medRxiv
. 2025 Feb;
PMID: 39973986
Background: Fragile X Syndrome (FXS) is a rare, neurodevelopmental disorder caused by a mutation to the Fragile X messenger ribonucleoprotein 1 () gene and characterized by sensory processing abnormalities and...
2.
McKinney W, Schmitt L, De Stefano L, Ethridge L, Norris J, Horn P, et al.
J Child Adolesc Psychopharmacol
. 2024 Dec;
PMID: 39651602
Treatment studies in knockout rodent models have found that minocycline and lovastatin each improve synaptic, neurological, and behavioral functioning, and open-label chronic dosing studies in human patients with fragile X...
3.
Rhoten S, Wenger M, De Stefano L
Cogn Affect Behav Neurosci
. 2024 Dec;
25(1):89-113.
PMID: 39638921
Iron deficiency (ID) is the most prevalent nutrient deficiency in the world, with a growing literature documenting the negative effects of ID on perception, attention, and memory. Animal models of...
4.
Ethridge L, Pedapati E, Schmitt L, Norris J, Auger E, De Stefano L, et al.
Sci Rep
. 2024 Oct;
14(1):22982.
PMID: 39362936
Recent failures translating preclinical behavioral treatment effects to positive clinical trial results in humans with Fragile X Syndrome (FXS) support refocusing attention on biological pathways and associated measures, such as...
5.
Ethridge L, Pedapati E, Schmitt L, Norris J, Auger E, De Stefano L, et al.
Res Sq
. 2024 Feb;
PMID: 38313274
Recent failures translating preclinical behavioral treatment effects to positive clinical trial results in humans with Fragile X Syndrome (FXS) support refocusing attention on biological pathways and associated measures, such as...
6.
Norris J, Schmitt L, De Stefano L, Pedapati E, Erickson C, Sweeney J, et al.
Front Integr Neurosci
. 2023 Feb;
17:898215.
PMID: 36816716
Introduction: Fragile X Syndrome (FXS) is rare genetic condition characterized by a repeat expansion (CGG) in the Fragile X messenger ribonucleoprotein 1 (FMR1) gene where individuals with greater than 200...
7.
Chen Y, Tang J, De Stefano L, Wenger M, Ding L, Craft M, et al.
Neuroimage
. 2022 Jan;
253:118926.
PMID: 35066158
Recent studies have emphasized the changes in large-scale brain networks related to healthy aging, with the ultimate purpose to aid in differentiating normal neurocognitive aging from neurodegenerative disorders that also...
8.
Wenger M, Townsend J, De Stefano L, Liu Y
Atten Percept Psychophys
. 2021 Dec;
84(1):101-123.
PMID: 34935122
The multidimensional generalization of signal detection theory known as General Recognition Theory (GRT, Ashby & Townsend, Psychological Review, 93, 154-179 1986) has been used to model and characterize the ways...
9.
Ethridge L, De Stefano L, Schmitt L, Woodruff N, Brown K, Tran M, et al.
Front Integr Neurosci
. 2019 Oct;
13:60.
PMID: 31649514
Sensory hypersensitivities are common and distressing features of Fragile X Syndrome (FXS). While there are many drug interventions that reduce behavioral deficits in Fmr1 mice and efforts to translate these...
10.
De Stefano L, Schmitt L, White S, Mosconi M, Sweeney J, Ethridge L
Front Integr Neurosci
. 2019 Aug;
13:34.
PMID: 31402856
Previous studies have found alterations in 40 Hz oscillatory activity in response to auditory stimuli in adults with Autism Spectrum Disorder (ASD). The current study sought to examine the specificity...